We are live on ! Find out more
URGN icon

UroGen Pharma
URGN

81 hedge funds and large institutions have $261M invested in UroGen Pharma in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

1% more funds holding

Funds holding: 80 → 81 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 26

2.34% less ownership

Funds ownership: 68.21% → 65.87% (-2.3%)

9% less capital invested

Capital invested by funds: $287M → $261M (-$25.7M)

59% less call options, than puts

Call options by funds: $2.05M | Put options by funds: $4.97M

Holders
81
Holders Change
+1
Holders Change %
+1.25%
% of All Funds
1.43%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
10
Increased
25
Reduced
26
Closed
9
Calls
$2.05M
Puts
$4.97M
Net Calls
-$2.91M
Net Calls Change
-$1.67M

Top Buyers

Rank Fund Capital Flow
1
RHJA
Rice Hall James & Associates
California
+$2.14M
2
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.2M
3
BlackRock
BlackRock
New York
+$920K
4
AIM
ARK Investment Management
Florida
+$829K
5
Renaissance Technologies
Renaissance Technologies
New York
+$687K

Top Sellers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
-$8.89M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.25M
3
PF
Phoenix Financial
Israel
-$1.72M
4
MIH
Meitav Investment House
Israel
-$934K
5
N
Nuveen
North Carolina
-$892K
Name Holding Trade Value Shares
Change 		Change in
Stake
LC
76
Lindbrook Capital
California
$6K -$272 -13 -4%
Simplex Trading
77
Simplex Trading
Illinois
$5K +$5.99K +286 New
S
78
SignatureFD
Georgia
$3K -$272 -13 -8%
Daiwa Securities Group
79
Daiwa Securities Group
Japan
$1K -$1.47K -70 -59%
QCG
80
Quadrant Capital Group
Ohio
$1K +$964 +46 +307%
AIG
81
American International Group
New York
$203 -$6.79K -324 -3%
Artisan Partners
82
Artisan Partners
Wisconsin
– -$8.89M -460,970 Closed
MIH
83
Meitav Investment House
Israel
– -$934K -48,407 Closed
Norges Bank
84
Norges Bank
Norway
– -$868K -45,000 Closed
Jane Street
85
Jane Street
New York
– -$419K -21,738 Closed
IC
86
IEQ Capital
California
– -$236K -12,250 Closed
AIM
87
Aigen Investment Management
New York
– -$207K -10,712 Closed
VCM
88
Vivaldi Capital Management
Illinois
– -$233K -10,000 Closed
CG
89
Cutler Group
California
– -$67K -3,500 Closed
SPIA
90
Steward Partners Investment Advisory
New York
– -$6K -300 Closed
1 2 3
4

URGN Hedge Fund Activity: Q4 2020 in Review

81 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in UroGen Pharma (URGN) for Q4 2020, worth a combined $261M — down 8.9% from $287M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new URGN positions and 9 closed out — a net gain of 1 holder — while 25 added to existing stakes and 26 trimmed.

The largest buyer was Rice Hall James & Associates, opening a new position worth an estimated $2.14M. The largest seller was Artisan Partners, exiting entirely with an estimated $8.89M sold.

  • 81 institutional investors held UroGen Pharma (URGN) as of Q4 2020, up from 80 in Q3 2020.
  • Funds reported $261M of UroGen Pharma stock for Q4 2020, down 8.9% quarter-over-quarter.
  • 10 funds opened new UroGen Pharma positions in Q4 2020 and 9 closed out, a net change of +1 holder.
  • The largest UroGen Pharma buyer in Q4 2020 was Rice Hall James & Associates, an estimated $2.14M added.
  • The largest UroGen Pharma seller in Q4 2020 was Artisan Partners, an estimated $8.89M sold.

Based on aggregated 13F filings for Q4 2020.